Rocky Mountain Diabetes Center has 3 current physicians with extensive training and experience in overseeing subjects in clinical trials. Dr. John Liljenquist (emeritus) paved the way with these trials for over 30 years and has overseen hundreds of studies. Drs. Carl Vance and Dave Liljenquist are continuing extensive research involvement having participated in clinical trials for over a decade. Dr. Joshua Smith is also contributing to clinical trials specifically targeting pediatric studies.
The research staff at Rocky Mountain Diabetes Center has over 130 years of combined of research experience. Our staff includes a Pharm.D. from Idaho State University who is a Certified Clinical Research Professional, and 7 certified research coordinators.
We have an excellent regulatory documents department that has developed unique methods of managing the ever-changing documents in such a way that many auditors have suggested it to be taught to other sites.
Because research in the medical field is always changing, our menu of current clinical trials is also very fluid. We frequently have trials for both Type 1 and Type 2 diabetes as well as diabetic neuropathy, diabetic nephropathy (kidney disease), hypertension, high cholesterol, and obesity. Our goal is to provide safe and effective clinical trials offering the newest investigational products and technologies while keeping our subjects engaged and providing the best care available.
Not only does our participation in clinical trials further the knowledge of diabetes and its treatment, but it offers our patients a chance to participate in these exciting trials as well. By participating in clinical trials, our patients are able to receive novel new treatments not yet available to the general public and are part of the momentum behind the growing knowledge base regarding diabetes, both type 1 and type 2, which is leading to more effective treatment.